SUMMARY An epidemiological and clinical study of multiple sclerosis (MS) in the Orkney and Shetland Islands showed that the prevalence rate of the disease is the highest in the world (309 and 184/100 000, respectively). The clinical entity, MS, is similar to that found in other parts of the world, except that optic neuritis not followed by MS is rare. Analysis of death certificates indicated that MS has probably occurred at the same rate in these islands for nearly a century. Although the incidence of MS is high, the incidence rate has remained constant over time. A rapidly increasing prevalence of MS has occurred in Orkney, with a more modest increase in Shetland, over the past 20 years, which is largely due to an increase in survival. Demographic factors, case ascertainment, and emigration have contributed little to the increasing prevalence of MS in these islands.
The names of patients with MS were obtained from the GPs, public health nurses, and officials of the local MS societies in the two islands. For each patient, two controls who did not have neurological disease and who were unrelated to the patient were selected. The first one, designated a parish control, was an individual who was born in the same parish and year as the patient and was of the same sex. A sample frame of 10 names (births on each side of the patient's) was derived for each patient from registers of birth located at the office in Edinburgh of the Registrar General for Scotland. No more than one year in either direction from the patient's date of birth was required to draw up a suitable sample frame. The names in the sample frame were placed in random order and intensive efforts were made to locate the first individual on the list. When all efforts to find the individual failed, the process was repeated with the subsequent names on the list until a control was found. The mean number of names utilised from the sample frames to find a parish control resident in Orkney and Shetland and willing to participate in the study was 2-5.
Because of the possibility that parish controls, by sharing a parish environment similar to that of the patients, might be overmatched for some aetiological factor, a second control was chosen. This control, designated a discontiguous control, was chosen by weighting all parishes by population in each set of islands in the census year closest to year of birth of the patient. A random number was then chosen and applied to the weighted alphabetical list of the parishes. If the initial parish selected was adjacent to that of the patient, it was discarded and a second random number was chosen and the procedure repeated until a discontiguous parish was selected. In only three instances was it necessary to repeat the random selection of parishes to find one not encroaching upon that of the patient. After selection of the discontiguous parish, the 10 births of the same sex closest to the patient's were selected, and this grouping constituted the discontiguous control panel. A mean number of 3 1 names was required to find a suitable discontiguous control from the panels of 10 randomly listed individuals. Five patients were not born in Orkney and Shetland, and no controls were chosen for them.
The most common reasons for the failure to find an individual from any given sample was 'Three patients in Orkney came to our attention after prevalence day (1 December 1974) and were not included in calculation of prevalence rate.
The age of onset of the disease in the two areas differed significantly. In Orkney, the mean age at onset was 33-6 years and in Shetland 29-0 years. In Shetland, 60% of the patients had onset before the age of 30.
Diagnosis It is tempting, from an epidemiological point of view, to regard these consistently observed features as manifesting two variants of the same disease, one marked by a young age at onset of the relapsing-remitting form with an excess in females, the other characterised by an older age at onset of the progressive form seen more commonly in males. It is widely believed that the course of the disease is influenced by age at onset. Just as striking in this series was the frequency with which the relapsing-remitting form of the disease occurred in females.
SYMPTOMS AT ONSET
Over 50% of the patients in the Orkney and Shetland series had an initial symptom referable to the spinal cord, as shown in Table 3 . Motor weakness was the most prominent symptom, followed by sensory disturbances, motor and sensory symptoms combined, and bladder dysfunction. Optic neuritis alone or in combination with other symptoms was observed in 15% of patients. Seventy per cent of patients were monosymptomatic at onset. Deceased patients in the Orkney and Shetland Islands who were included in at least one of the four surveys had a mean duration of the disease of 22 years and 27 years respectively. This group must necessarily include early deaths; therefore, the duration of the disease for the total patient population is probably greater.
An indirect method for determining duration was proposed by Poskanzer et al.6 Assuming that there is no change in the pattern of a disease, average duration can be estimated as twice the period from onset to prevalence day. It is further assumed that the duration among a group of patients identified on prevalence day will approximate to a normal distribution and that ascertainment of nearly all existing cases will be achieved, especially those cases with recent onset of the disease. The latter requirement has probably not been fully met in each of the four surveys in the islands. However, the method can be applied by using information discovered later about cases with onset close to prevalence day. (Fig. 4) . While the number of cases with onset within 10 and 20 years of prevalence day remained relatively constant over the four investigations, the proportion of cases with onset greater than 20 years before prevalence day increased steadily over time (X2 = 23-6, 3 ' In Orkney, the proportion of the population aged 50-69 increased from 20-4% in 1951 to 25-6% in 1971. In Shetland, the increase was more modest, from 22-7% in 1951 to 25-3% in 1961, followed by a slight decrease in 1971 to 23-6%. alterations in patterns of fertility. The ' by correcting the prevalence rates in the four studies for all cases known to exist at the time but not ascertained. Rates were recalculated using the population figures of 1951-the largest population before decline due to emigration (Table 9 ). This correction assumes that cases did not emigrate while well individuals did. With these two corrections, the prevalence rates in both Orkney and Shetland are unchanging, but no allowance is made in this calculation for cases not yet ascertained.
Conclusions
Clinical MS in the Orkney and Shetland Islands appears to be similar to that found in other parts of the world, except that optic neuritis not followed by MS occurs with considerably less frequency than in other studies. The age of onset of the disease was somewhat later in Orkney than in Shetland patients (33.6 compared with 29*0 years). The rate of possible cases was remarkably similar in the two islands (17% and 18%). Despite 
